Innovus Pharmaceuticals Inc. (fka INNV)

[gi197845]

I sure hope Dr.Damaj isn't over promising with this statement...

"The Company currently expects between $10-15 million in additional revenue from the sales of FlutiCare™ in the U.S. in the first full 12 months from the launch date."

I say this because Damaj has been over estimating revenue and when Fluticare will be approved...

In my opinion, it's better to under estimate/under promise a bit and over deliver.

Keep in mind, INNV can't sell Fluticare world wide yet, the FDA will probably delay the ANDA Fluticare review or rejection until 12/31/2018, per the bribes and kick-backs from GSK and Bayer...

Pharma and the stock market can be a swamp, much like the government...